Follow us on:

Linkedin Facebook

FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Entain plc

Entain H1 2025 results beat expectations, FY guidance upgraded

Entain plc reported a 7% rise in total group net gaming revenue for H1 2025, including a 35% constant currency increase from BetMGM. Online performance exceeded forecasts, with UK & Ireland up 21% and Brazil up 21%...
Spirax Group

Spirax Group Plc reports organic growth and dividend increase in H1 results

Spirax Group reported half-year revenue of £822.2m, down 1% reported but up 3% organically, with adjusted operating profit rising 7% organically to £158.8m. Statutory profit was affected by restructuring costs and currency headwinds, while adjusted cash conversion improved to 61%...
GSK

GSK’s Gepotidacin receives US FDA Priority Review for gonorrhoea treatment

GSK has announced that the US FDA has accepted for priority review a supplemental New Drug Application for gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea in patients aged 12 and over...
GSK plc

GSK to receive $370m settlement and royalties from mRNA patent agreement

GSK will receive a $370 million upfront payment, plus 1% royalties on US sales of certain mRNA vaccines by BioNTech and Pfizer, following a settlement linked to CureVac’s recent agreement with BioNTech...
Hikma Pharmaceuticals plc

Hikma Pharmaceuticals reports 6% revenue growth and confirms FY outlook

Hikma Pharmaceuticals posted a 6% rise in H1 2025 revenue to $1.66 billion, supported by strong Injectables and Branded sales. Core operating profit declined 7% due to product mix and prior-year comparators, but the company expects a stronger H2...
Hiscox Ltd

Hiscox Ltd reports profitable growth across all divisions in H1 2025

Hiscox delivered 5.7% growth in written premiums to $2.94bn and maintained strong profitability with a 92.6% combined ratio. Retail margins expanded, investment income rose to $234.9m, and operating return on tangible equity reached 14.5%...
Legal & General

Legal & General grows core EPS by 9% as strategic focus strengthens

Legal & General reported a 9% rise in core operating EPS and a 6% increase in core operating profit to £859m for H1 2025. The group recorded £5.2bn of new Institutional Retirement business and grew Workplace pension assets to over £100bn...
Coca Cola

Coca-Cola HBC reports 9.9% organic revenue growth in H1 2025

Coca-Cola HBC delivered 9.9% organic revenue growth and a 15.2% rise in reported EBIT to €649.8m for H1 2025, driven by strong performance in Emerging markets, pricing initiatives, and innovation across its 24/7 portfolio...
Smith & Nephew plc

Smith & Nephew Plc delivers strong H1 with profit up 31%

Smith+Nephew reported 5.0% underlying revenue growth and a 30.6% rise in operating profit for H1 2025. EPS rose 36.6% to 33.5¢ and free cash flow surged to $244m. The company also announced a $500m share buyback for H2, supported by strong cash generation and margin expansion...
Diageo

Diageo Plc FY25 profit down 28%, free cash flow rises to $2.7bn

Diageo reported FY25 operating profit of $4.3bn, down 27.8%, impacted by exceptional costs and currency headwinds. Organic net sales rose 1.7%, while free cash flow increased to $2.7bn. The group raised its cost savings target to $625m and reaffirmed its outlook for mid-single-digit profit growth in FY26...
BP plc

BP Plc reports $2.4bn Q2 underlying profit, launches $750m buyback

BP delivered a $2.4bn underlying replacement cost profit in Q2 2025, supported by strong trading and refining margins. Operating cash flow reached $6.3bn, and net debt fell to $26.0bn. The company declared a dividend of 8.32 cents per share and announced a $750m share buyback...
Fresnillo

Fresnillo H1 profit up 297% with $1bn free cash flow and higher dividend

Fresnillo plc reported a 297% rise in H1 2025 profit to $467.6m, driven by stronger metals prices, disciplined cost control, and a 16% increase in gold output. Free cash flow rose to $1.03bn, supporting a 20.8 cent interim dividend...
Pearson Plc

Pearson Plc on track to deliver 2025 guidance

Pearson plc reported H1 2025 sales of £1.72 billion, up 2% on an underlying basis, with adjusted operating profit also rising 2% to £242 million. Free cash flow jumped £129 million to £156 million, boosted by a £114 million State Aid tax recovery...

Intertek Group delivers strong H1 2025 with double-digit EPS growth

Intertek Group plc reported H1 2025 revenue of £1.67 billion, up 4.5% at constant currency, with adjusted EPS rising 12.6%. Operating profit increased 9.7% to £276.3 million and margin improved by 80bps...
International Airlines Group

IAG reports €1.88bn H1 profit on strong travel demand

International Consolidated Airlines Group posted a 43.5% rise in H1 2025 operating profit to €1.88 billion, driven by resilient passenger demand, lower fuel costs and strong performance across its brands...
BAE Systems

BAE Systems upgrades 2025 outlook after strong H1 performance

BAE Systems reported an 11% rise in H1 sales to £14.6bn and a 13% increase in underlying EBIT to £1.55bn, prompting an upgrade to full-year sales and profit guidance...
Sage Group plc

Sage Group Plc reports 9% revenue growth, reaffirms FY25 outlook

Sage Group (LON:SGE) reported a 9% year-on-year rise in total revenue to £1.86bn for the nine months to 30 June 2025. Strong growth was driven by Sage Business Cloud (+13%) and recurring revenue (+10%)...
GSK plc

GSK raises 2025 guidance after strong Q2 performance

GSK reported Q2 2025 turnover of £8.0bn, up 6% CER, with strong growth in Specialty Medicines (+15%) and Vaccines (+9%). Core EPS rose 15% to 46.5p...
Glencore

Glencore delivers 5% H1 CuEq growth and $1bn cost savings plan

Glencore has reported a 5% year-on-year increase in copper equivalent production for H1 2025, driven by the integration of EVR’s steelmaking coal volumes. Copper output declined due to planned sequencing, cobalt and zinc production rose...
Croda International

Croda H1 2025 sales Up 7% with adjusted profit before tax up 8%

Croda International delivered group sales of £855.8 m in the half year to 30 June 2025, up 7% at constant currency, with adjusted EBITDA rising 11% to £198.5 m and adjusted operating profit up 12% to £146.9 m...

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

Industrials

Entain plc

Entain H1 2025 results beat expectations, FY guidance upgraded

Entain plc reported a 7% rise in total group net gaming revenue for H1 2025, including a 35% constant currency increase from BetMGM. Online performance exceeded forecasts, with UK & Ireland up 21% and Brazil up 21%...
Spirax Group

Spirax Group Plc reports organic growth and dividend increase in H1 results

Spirax Group reported half-year revenue of £822.2m, down 1% reported but up 3% organically, with adjusted operating profit rising 7% organically to £158.8m. Statutory profit was affected by restructuring costs and currency headwinds, while adjusted cash conversion improved to 61%...
GSK

GSK’s Gepotidacin receives US FDA Priority Review for gonorrhoea treatment

GSK has announced that the US FDA has accepted for priority review a supplemental New Drug Application for gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea in patients aged 12 and over...
GSK plc

GSK to receive $370m settlement and royalties from mRNA patent agreement

GSK will receive a $370 million upfront payment, plus 1% royalties on US sales of certain mRNA vaccines by BioNTech and Pfizer, following a settlement linked to CureVac’s recent agreement with BioNTech...
Hikma Pharmaceuticals plc

Hikma Pharmaceuticals reports 6% revenue growth and confirms FY outlook

Hikma Pharmaceuticals posted a 6% rise in H1 2025 revenue to $1.66 billion, supported by strong Injectables and Branded sales. Core operating profit declined 7% due to product mix and prior-year comparators, but the company expects a stronger H2...
Hiscox Ltd

Hiscox Ltd reports profitable growth across all divisions in H1 2025

Hiscox delivered 5.7% growth in written premiums to $2.94bn and maintained strong profitability with a 92.6% combined ratio. Retail margins expanded, investment income rose to $234.9m, and operating return on tangible equity reached 14.5%...
Legal & General

Legal & General grows core EPS by 9% as strategic focus strengthens

Legal & General reported a 9% rise in core operating EPS and a 6% increase in core operating profit to £859m for H1 2025. The group recorded £5.2bn of new Institutional Retirement business and grew Workplace pension assets to over £100bn...
Coca Cola

Coca-Cola HBC reports 9.9% organic revenue growth in H1 2025

Coca-Cola HBC delivered 9.9% organic revenue growth and a 15.2% rise in reported EBIT to €649.8m for H1 2025, driven by strong performance in Emerging markets, pricing initiatives, and innovation across its 24/7 portfolio...
Smith & Nephew plc

Smith & Nephew Plc delivers strong H1 with profit up 31%

Smith+Nephew reported 5.0% underlying revenue growth and a 30.6% rise in operating profit for H1 2025. EPS rose 36.6% to 33.5¢ and free cash flow surged to $244m. The company also announced a $500m share buyback for H2, supported by strong cash generation and margin expansion...
Diageo

Diageo Plc FY25 profit down 28%, free cash flow rises to $2.7bn

Diageo reported FY25 operating profit of $4.3bn, down 27.8%, impacted by exceptional costs and currency headwinds. Organic net sales rose 1.7%, while free cash flow increased to $2.7bn. The group raised its cost savings target to $625m and reaffirmed its outlook for mid-single-digit profit growth in FY26...
BP plc

BP Plc reports $2.4bn Q2 underlying profit, launches $750m buyback

BP delivered a $2.4bn underlying replacement cost profit in Q2 2025, supported by strong trading and refining margins. Operating cash flow reached $6.3bn, and net debt fell to $26.0bn. The company declared a dividend of 8.32 cents per share and announced a $750m share buyback...
Fresnillo

Fresnillo H1 profit up 297% with $1bn free cash flow and higher dividend

Fresnillo plc reported a 297% rise in H1 2025 profit to $467.6m, driven by stronger metals prices, disciplined cost control, and a 16% increase in gold output. Free cash flow rose to $1.03bn, supporting a 20.8 cent interim dividend...
Pearson Plc

Pearson Plc on track to deliver 2025 guidance

Pearson plc reported H1 2025 sales of £1.72 billion, up 2% on an underlying basis, with adjusted operating profit also rising 2% to £242 million. Free cash flow jumped £129 million to £156 million, boosted by a £114 million State Aid tax recovery...

Intertek Group delivers strong H1 2025 with double-digit EPS growth

Intertek Group plc reported H1 2025 revenue of £1.67 billion, up 4.5% at constant currency, with adjusted EPS rising 12.6%. Operating profit increased 9.7% to £276.3 million and margin improved by 80bps...
International Airlines Group

IAG reports €1.88bn H1 profit on strong travel demand

International Consolidated Airlines Group posted a 43.5% rise in H1 2025 operating profit to €1.88 billion, driven by resilient passenger demand, lower fuel costs and strong performance across its brands...
BAE Systems

BAE Systems upgrades 2025 outlook after strong H1 performance

BAE Systems reported an 11% rise in H1 sales to £14.6bn and a 13% increase in underlying EBIT to £1.55bn, prompting an upgrade to full-year sales and profit guidance...
Sage Group plc

Sage Group Plc reports 9% revenue growth, reaffirms FY25 outlook

Sage Group (LON:SGE) reported a 9% year-on-year rise in total revenue to £1.86bn for the nine months to 30 June 2025. Strong growth was driven by Sage Business Cloud (+13%) and recurring revenue (+10%)...
GSK plc

GSK raises 2025 guidance after strong Q2 performance

GSK reported Q2 2025 turnover of £8.0bn, up 6% CER, with strong growth in Specialty Medicines (+15%) and Vaccines (+9%). Core EPS rose 15% to 46.5p...
Glencore

Glencore delivers 5% H1 CuEq growth and $1bn cost savings plan

Glencore has reported a 5% year-on-year increase in copper equivalent production for H1 2025, driven by the integration of EVR’s steelmaking coal volumes. Copper output declined due to planned sequencing, cobalt and zinc production rose...
Croda International

Croda H1 2025 sales Up 7% with adjusted profit before tax up 8%

Croda International delivered group sales of £855.8 m in the half year to 30 June 2025, up 7% at constant currency, with adjusted EBITDA rising 11% to £198.5 m and adjusted operating profit up 12% to £146.9 m...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

FTSE 100

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple